Results 241 to 250 of about 661,408 (292)

Biochar in the circular bioeconomy: a bibliometric analysis of technologies, applications, and trends

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biochar has attracted considerable attention in recent years for its wide‐ranging applications, particularly its role in carbon sequestration as a strategy to mitigate greenhouse gas emissions. Its emerging uses within the circular bioeconomy also position it as a valuable tool for environmental management, and ongoing research continues to ...
Jean Agustin Velasquez‐Pinas, Parisa Ghofrani‐Isfahani, Diego Yepes Maya, Giulia Ravenni, Luiz Eduardo Nochi Castro, Irini Angelidaki, Tânia Forster‐Carneiro   +6 more
wiley   +1 more source

Gut microbiota alterations are linked to COVID-19 severity in North African and European populations. [PDF]

NPJ Biofilms Microbiomes
Bredon M, Hausfater P, Khalki L, Tijani Y, Cheikh A, Brot L, Creusot L, Rolhion N, Trottein F, Lambeau G, Georgin-Lavialle S, Bleibtreu A, Baudel JL, Lefèvre A, Emond P, Tubach F, Simon-Tillaux N, Simon T, Gorochov G, Zaid Y, Sokol H.   +20 more
europepmc   +1 more source

Biotechnological production of 2‐phenylethanol from agroindustrial byproducts: experimental evaluation, techno‐economic analysis, and life cycle assessment

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract 2‐Phenylethanol (2‐PE) is an alcohol with a rosy scent, commonly used as a fragrance, flavoring agent, and preservative in food and cosmetics. This study evaluates 2‐PE bioproduction using apple pomace and whey as low‐cost, biobased substrates for the growth of the yeast strain Kluyveromyces marxianus CBS600.
Fernanda Thimoteo Azevedo Jorge, Nurdana Orynbek, Aiganym Abduraimova, Anastasiya Valakhanovich, Hector Adiel Flores‐Nestor, Marwen Moussa, Claire Saulou‐Bérion, Ana Karen Sánchez‐Castañeda   +7 more
wiley   +1 more source

Impact of maintenance treatment on male gonadal function in patients treated for localized rhabdomyosarcoma in RMS2005 trial in France. [PDF]

Cancer
Rossillon L, Thomas-Teinturier C, Orbach D, Tabone MD, Bertrand A, Ansoborlo S, Defachelles AS, Rome A, Haouy S, Plantaz D, Bolle S, Bernier-Chastagner V, Guerin F, Sarnacki S, Philippe-Chomette P, Allodji R, Lenez L, Métayer L, Barraud-Lange V, Minard-Colin V, Fresneau B.   +20 more
europepmc   +1 more source

Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the effect of a potent cytochrome P450 (CYP) 3A inhibitor and CYP inducer on the pharmacokinetics of ritlecitinib, a JAK3/TEC family kinase inhibitor, and assess the effect of ritlecitinib on the pharmacokinetics of CYP substrates (midazolam, efavirenz, tolbutamide, caffeine and oral contraceptives [ethinyl oestradiol and levonorgestrel])
Vivek S. Purohit, Yeamin Huh, Martin E. Dowty, Anna Plotka, Alexandre Lejeune, Hindu Kalluru, Brian Hee   +6 more
wiley   +1 more source

Effects of the COVID-19 Pandemic on the Performance of Marathon Runners. [PDF]

Transl Sports Med
Lluch J, Martínez-Giménez F, Abad F, Garrido Martínez J.   +3 more
europepmc   +1 more source

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza, Michaela Semeraro, Gabrielle Lui, Léo Froelicher‐Bournaud, Laure Choupeaux, Jean‐Marc Treluyer, Sihem Benaboud, Joelle Terzic, Eric Hachulla, Philippe Remy, Jérôme Harambat, Alexandre Karras, Caroline Rousset‐Rouviere, Anne Jolivot, Zahir Amoura, Eric Daugas, Aurélie Hummel, Rémi Salomon, Jean‐Christophe Lega, Stéphane Decramer, Alexandre Belot, Delphine Gobert, Nathalie Costedoat‐Chalumeau, Stanislas Faguer, Isabelle Melki, Noémie Jourde‐Chiche, Brigitte Bader‐Meunier   +26 more
wiley   +1 more source

Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profiles. [PDF]

Acta Neuropathol Commun
Tauziède-Espariat A, Dangouloff-Ros V, Sievers P, Duchesne M, Siegfried A, Nicaise Y, Boddaert N, Hasty L, Métais A, Ngo C, le Loarer F, Bouvier C, Fontaine A, Rousseau A, Marguet F, Beccaria K, Blauwblomme T, Uro-Coste E, Varlet P, RENOCLIP-LOC.   +19 more
europepmc   +1 more source

Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents

British Journal of Clinical Pharmacology, EarlyView.
Aims We sought to characterize adverse events and deaths associated with the use of psychoactive substances in children and adolescents. Methods Two French Addictovigilance databases were analysed: spontaneous reports and deaths over the period 2016–2021, in subjects aged 10–<18 years. An unsupervised classification was implemented on consumption data (
Hélène Peyrière, Anne Batisse, Nathalie Fouilhé Sam‐Laï, Amélie Daveluy, Christine Fournier‐Choma, Sylvie Deheul, Cécile Chevalier, Clémence Lacroix, Valérie Gibaja, Aurélie Aquizerate, Stéphanie Pain, Emilie Jouanjus, Marie‐Christine Picot, Erika Nogue   +13 more
wiley   +1 more source

A look back at the Virology Departmental Days of the Institut Pasteur (Le Touquet, May 13-15, 2024). [PDF]

J Mol Cell Biol
González R, Koh C, Virlon B, Merkling SH, Vartanian JP.   +4 more
europepmc   +1 more source